[{"id":"38c385ac-468a-477f-bc1a-8c1aa2d2b496","acronym":"U-CART","url":"https://clinicaltrials.gov/study/NCT03229876","created_at":"2021-01-18T15:56:32.604Z","updated_at":"2024-07-02T16:35:42.182Z","phase":"","brief_title":"Safety and Efficacy Evaluation of CD19-UCART","source_id_and_acronym":"NCT03229876 - U-CART","lead_sponsor":"Bioray Laboratories","biomarkers":" CD19","pipe":" | ","alterations":" CD19 positive • CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 positive • CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • BRL-301"],"overall_status":"Suspended","enrollment":" Enrollment 20","initiation":"Initiation: 06/01/2019","start_date":" 06/01/2019","primary_txt":" Primary completion: 12/15/2023","primary_completion_date":" 12/15/2023","study_txt":" Completion: 12/30/2023","study_completion_date":" 12/30/2023","last_update_posted":"2023-07-24"}]